Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,530Revenue (TTM) $M1,573Net Margin (%)64.3Altman Z-Score13.4
Enterprise Value $M4,586EPS (TTM) $20.6Operating Margin %75.7Piotroski F-Score8
P/E(ttm)6.2Beneish M-Score-1.6Pre-tax Margin (%)98.1Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %--Quick Ratio4.2Cash flow > EarningsN
Price/Sales4.05-y EBITDA Growth Rate %36.3Current Ratio4.5Lower Leverage y-yY
Price/Free Cash Flow14.7y-y EBITDA Growth Rate %410ROA % (ttm)48.3Higher Current Ratio y-yY
Dividend Yield %--PEG0.2ROE % (ttm)66.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M43.5ROIC % (ttm)114Gross Margin Increase y-yY

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
UTHRDavid Dreman 2016-06-30 Add0.17%$98.33 - $121.03
($111.54)
$ 127.2114%Add 2036.00%2,670
UTHRJoel Greenblatt 2016-06-30 Add0.01%$98.33 - $121.03
($111.54)
$ 127.2114%Add 1.24%367,075
UTHRJoel Greenblatt 2016-03-31 Add0.04%$108.47 - $156.61
($127.11)
$ 127.210%Add 10.43%362,565
UTHRGeorge Soros 2016-03-31 Sold Out -0.01%$108.47 - $156.61
($127.11)
$ 127.210%Sold Out0
UTHRDavid Dreman 2016-03-31 Buy $108.47 - $156.61
($127.11)
$ 127.210%New holding125
UTHRKen Fisher 2016-03-31 Reduce$108.47 - $156.61
($127.11)
$ 127.210%Reduce -1.43%3,092
UTHRFirst Eagle Investment 2015-12-31 Sold Out -0.18%$119.57 - $160.91
($146.21)
$ 127.21-13%Sold Out0
UTHRJoel Greenblatt 2015-12-31 Add0.05%$119.57 - $160.91
($146.21)
$ 127.21-13%Add 9.00%328,310
UTHRGeorge Soros 2015-12-31 Buy 0.01%$119.57 - $160.91
($146.21)
$ 127.21-13%New holding4,400
UTHRKen Fisher 2015-12-31 Add$119.57 - $160.91
($145.83)
$ 127.21-13%Add 7.51%3,137
UTHRJoel Greenblatt 2015-09-30 Add0.05%$131.24 - $179.15
($160.64)
$ 127.21-21%Add 15.35%301,205
UTHRFirst Eagle Investment 2015-09-30 Add0.04%$131.24 - $179.15
($160.64)
$ 127.21-21%Add 28.56%548,807
UTHRKen Fisher 2015-09-30 Add$131.24 - $179.15
($160.64)
$ 127.21-21%Add 19.10%2,918
UTHRJoel Greenblatt 2015-06-30 Reduce-0.04%$159.69 - $188.56
($179.77)
$ 127.21-29%Reduce -10.29%261,125
UTHRFirst Eagle Investment 2015-06-30 Add0.02%$159.69 - $188.56
($179.77)
$ 127.21-29%Add 14.57%426,880
UTHRJoel Greenblatt 2015-03-31 Reduce-0.03%$124.93 - $179.51
($152.45)
$ 127.21-17%Reduce -9.91%291,077
UTHRFirst Eagle Investment 2015-03-31 Add$124.93 - $179.51
($152.45)
$ 127.21-17%Add 3.44%372,580
UTHRKen Fisher 2015-03-31 Buy $124.93 - $179.51
($152.45)
$ 127.21-17%New holding2,450
UTHRFirst Eagle Investment 2014-12-31 Add0.03%$122.11 - $134.8
($128.83)
$ 127.21-1%Add 37.43%360,180
UTHRJoel Greenblatt 2014-09-30 Reduce-0.4%$86.44 - $136.16
($102.87)
$ 127.2124%Reduce -55.36%288,401
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

UTHR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROTHBLATT MARTINE AChairman & CEO 2016-09-15Sell1,258$122.343.98view
ROTHBLATT MARTINE AChairman & CEO 2016-09-08Sell1,254$123.443.05view
ROTHBLATT MARTINE AChairman & CEO 2016-09-01Sell1,257$122.813.58view
PATUSKY CHRISTOPHERDirector 2016-09-01Sell5,000$122.733.65view
ROTHBLATT MARTINE AChairman & CEO 2016-08-25Sell1,250$125.291.53view
ROTHBLATT MARTINE AChairman & CEO 2016-08-18Sell1,249$125.881.06view
ROTHBLATT MARTINE AChairman & CEO 2016-08-11Sell1,253$124.092.51view
ROTHBLATT MARTINE AChairman & CEO 2016-08-04Sell1,249$125.781.14view
ROTHBLATT MARTINE AChairman & CEO 2016-07-28Sell1,271$117.058.68view
ROTHBLATT MARTINE AChairman & CEO 2016-07-21Sell1,284$112.7712.8view

Quarterly/Annual Reports about UTHR:

News about UTHR:

Articles On GuruFocus.com
These Five Stocks Show a Combination of Value and Growth Aug 03 2016 
Worst Performance YTD: MasterCard, Lazard Aug 03 2016 
5 Mid-Cap Stocks With Low Enterprise Multiples Aug 03 2016 
10 Biotech and Specialty Pharma Bargains: Do You Have the Guts to Speculate? Jul 01 2016 
Gurus Invest in Top Biotechnology Stocks Jun 20 2016 
United Therapeutics Is a Value Investor's Biotech Dream Apr 28 2016 
Cummins and Deckers are Candidates for a January Bounce Nov 20 2015 
Estimated Revenue Up 5% Stock Screen Nov 18 2015 
FDA Approval Of Cancer Drug Catapults United Therapeutics Shares By 2% Mar 11 2015 
Weekly CFO Sells Highlight: United Therapeutics Corp, Williams Companies Inc, Facebook Inc. Oct 12 2014 

More From Other Websites
Analyst Has 3 Biotech Stocks to Buy With Over 100% Upside Potential Sep 22 2016
How Analysts See United Therapeutics’ Continued Performance Sep 01 2016
ETF’s with exposure to United Therapeutics Corp. : August 31, 2016 Aug 31 2016
Physician and Payer Relationships to Increase UTHR’s Drug Access Aug 31 2016
United Therapeutics Makes Novel Technologies a Priority Aug 31 2016
United Therapeutics’ Research Efforts Key to Boosting Stock Aug 31 2016
$1 Billion Sales Target in Place for Tyvaso Aug 30 2016
Generic Competition Not a Threat to UTHR’s Remodulin Aug 30 2016
Strong Growth Projected for UTHR’s Hypertension Drugs Aug 30 2016
Why UTHR Trades at Lower Multiples Compared to Its Peers Aug 30 2016
United Therapeutics Hurt By Competitive Pressure Aug 22 2016
United Therapeutics Corporation To Present At The 2016 Wedbush PacGrow Healthcare Conference Aug 10 2016
ETF’s with exposure to United Therapeutics Corp. : August 5, 2016 Aug 05 2016
United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 4, 2016 Aug 04 2016
These Five Stocks Show a Combination of Value and Growth Aug 03 2016
Worst Performance YTD: MasterCard, Lazard Aug 03 2016
5 Mid-Cap Stocks With Low Enterprise Multiples Aug 03 2016
UNITED THERAPEUTICS CORP Financials Aug 03 2016
Inside Amgen’s Analyst Recommendations for 2016 Aug 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)